You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Johnson and Johnson
Boehringer Ingelheim
McKinsey
Colorcon

Last Updated: March 6, 2021

DrugPatentWatch Database Preview

Cefaclor - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for cefaclor and what is the scope of patent protection?

Cefaclor is the generic ingredient in four branded drugs marketed by Lilly, Ceph Intl, Dava Pharms Inc, Heritage Pharma, Hikma, Ivax Sub Teva Pharms, Ranbaxy, Teva, Yung Shin Pharm, Facta Farma, Watson Labs Inc, Ranbaxy Labs Ltd, and World Gen, and is included in thirty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for cefaclor. Six suppliers are listed for this compound.

Summary for cefaclor
Drug Prices for cefaclor

See drug prices for cefaclor

Recent Clinical Trials for cefaclor

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of LouisvillePhase 0
Julio RamirezPhase 0
James Graham Brown Cancer CenterPhase 0

See all cefaclor clinical trials

Pharmacology for cefaclor
Medical Subject Heading (MeSH) Categories for cefaclor

US Patents and Regulatory Information for cefaclor

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dava Pharms Inc CEFACLOR cefaclor FOR SUSPENSION;ORAL 064110-001 Apr 28, 1995 DISCN No No   Start Trial   Start Trial   Start Trial
Teva CEFACLOR cefaclor TABLET, EXTENDED RELEASE;ORAL 065058-002 Sep 4, 2002 RX No Yes   Start Trial   Start Trial   Start Trial
Ranbaxy CEFACLOR cefaclor CAPSULE;ORAL 064156-002 Aug 28, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Teva CEFACLOR cefaclor CAPSULE;ORAL 064145-002 Jun 24, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Lilly CECLOR cefaclor CAPSULE;ORAL 050521-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Medtronic
Merck
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.